The $40m fund will invest in spinouts originating from research from the Canadian university.
The University of British Columbia and the Canadian province’s government investment vehicle InBC have launched a $40m fund to invest in spinouts from the university.
The Canadian university has contributed $10m to the UBC Catalyst Ventures Fund, with another $10m from the provincial government fund. Another $20m is being raised from private sector investors.
The fund will invest in life science and deep tech companies created from university research and spinouts established by university faculty, staff, students and recent alumni.
The University of British Columbia has spun off more than 280 companies. Notable spinouts include AbCellera, a clinical stage biotechnology company focused on antibody-based medicines in endocrinology, women’s health, immunology and oncology; Xenon Pharmaceuticals, a company developing medicines for neurological conditions; and Aspect Biosystems, a regenerative medicine biotech company.
Check out Global University Venturing’s list of university venture funds globally
